Senda Biosciences
About:
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Website: https://www.sendabiosciences.com/
Twitter/X: sendabioscience
Top Investors: Alexandria Venture Investments, Mayo Clinic, Qatar Investment Authority, Stage 1 Ventures, Partners Investment
Description:
Senda Biosciences is a developer of therapeutic applications intended for novel treatments of human disease. The company studies the molecular relationships between bacterial, botanical, and human cells as well as how they define health and disease, providing medical professionals with novel medications and delivery methods. Senda Biosciences was established in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts.
$309M
$10M to $50M
Cambridge, Massachusetts, United States
2017-01-01
press(AT)sendabiosciences.com
David Berry, David Kolesky, Ignacio Martinez, John Casey
51-100
2022-08-16
Private
© 2025 bioDAO.ai